• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Adherence to prophylactic dual antiplatelet therapy in patients with acute coronary syndrome - A study conducted at a Saudi university hospital.急性冠状动脉综合征患者预防性双联抗血小板治疗的依从性——在沙特一所大学医院开展的一项研究。
Saudi Pharm J. 2020 Mar;28(3):369-373. doi: 10.1016/j.jsps.2020.01.018. Epub 2020 Feb 3.
2
Patient perspectives of nuisance bleeding and adherence to dual antiplatelet therapy: a qualitative study.患者对轻微出血及双联抗血小板治疗依从性的看法:一项定性研究
Open Heart. 2020 Oct;7(2). doi: 10.1136/openhrt-2020-001405.
3
Prevalence and risk factors of non-adherence to antipsychotic medications in Saudi Arabia.沙特阿拉伯抗精神病药物治疗依从性不佳的患病率及危险因素
Int J Clin Pharmacol Ther. 2023 Mar;61(3):111-121. doi: 10.5414/CP204300.
4
Adherence to dual antiplatelet therapy after coronary stenting: A study conducted at two Vietnamese hospitals.冠状动脉支架置入术后双联抗血小板治疗的依从性:在两家越南医院开展的一项研究。
J Cardiovasc Thorac Res. 2021;13(4):330-335. doi: 10.34172/jcvtr.2021.52. Epub 2021 Dec 5.
5
Validation of an Arabic Version of the Self-Efficacy for Appropriate Medication Use Scale.验证适当用药自我效能量表的阿拉伯语版本。
Int J Environ Res Public Health. 2021 Nov 15;18(22):11983. doi: 10.3390/ijerph182211983.
6
Effect of acute coronary syndrome patients' education on adherence to dual antiplatelet therapy.急性冠状动脉综合征患者教育对双联抗血小板治疗依从性的影响
J Saudi Heart Assoc. 2017 Oct;29(4):252-258. doi: 10.1016/j.jsha.2017.02.003. Epub 2017 Mar 8.
7
Factors associated with adherence to medication among depressed patients from Saudi Arabia: a cross-sectional study.沙特阿拉伯抑郁患者药物治疗依从性相关因素的横断面研究。
Neuropsychiatr Dis Treat. 2014 Oct 28;10:2031-7. doi: 10.2147/NDT.S71697. eCollection 2014.
8
Self-Medication Among King Khalid University Students, Saudi Arabia.沙特阿拉伯哈利德国王大学学生的自我药疗情况
Risk Manag Healthc Policy. 2019 Nov 14;12:243-249. doi: 10.2147/RMHP.S230257. eCollection 2019.
9
Factors predicting medication adherence among coronary artery disease patients in Saudi Arabia: A descriptive study.预测沙特阿拉伯冠状动脉疾病患者药物依从性的因素:一项描述性研究。
Saudi Med J. 2023 Sep;44(9):904-911. doi: 10.15537/smj.2023.44.9.20230293.
10
Adherence to Medical Treatment and Its Determinants Among Adult Saudi Glaucoma Patients in Riyadh City.利雅得市成年沙特青光眼患者的药物治疗依从性及其决定因素
Cureus. 2020 Feb 2;12(2):e6847. doi: 10.7759/cureus.6847.

引用本文的文献

1
A Prospective Cross-Sectional Study of Acute Coronary Syndrome Patients' Quality of Life and Drug Prescription Patterns at Riyadh Region Hospitals, Saudi Arabia.沙特阿拉伯利雅得地区医院急性冠状动脉综合征患者生活质量与药物处方模式的前瞻性横断面研究
Healthcare (Basel). 2023 Jul 7;11(13):1973. doi: 10.3390/healthcare11131973.
2
Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study.利用远程心脏病学药剂师诊所优化急性冠状动脉综合征患者二级预防药物的依从性:一项匹配队列研究。
Int J Clin Pharm. 2023 Jun;45(3):722-730. doi: 10.1007/s11096-023-01562-4. Epub 2023 Mar 20.

本文引用的文献

1
Antiplatelet Therapy in Acute Coronary Syndrome.急性冠状动脉综合征中的抗血小板治疗
Eur Cardiol. 2017 Aug;12(1):33-37. doi: 10.15420/ecr.2016:34:2.
2
Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction.心肌梗死后患者使用慢性病治疗依从性量表评估的治疗依从性。
Patient Prefer Adherence. 2018 Mar 5;12:333-340. doi: 10.2147/PPA.S150435. eCollection 2018.
3
Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome.急性冠脉综合征患者双联抗血小板治疗超过一年的患病率及预测因素
PLoS One. 2017 Oct 23;12(10):e0186961. doi: 10.1371/journal.pone.0186961. eCollection 2017.
4
Effect of acute coronary syndrome patients' education on adherence to dual antiplatelet therapy.急性冠状动脉综合征患者教育对双联抗血小板治疗依从性的影响
J Saudi Heart Assoc. 2017 Oct;29(4):252-258. doi: 10.1016/j.jsha.2017.02.003. Epub 2017 Mar 8.
5
Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.急性冠状动脉综合征经皮冠状动脉介入治疗患者双联抗血小板治疗的持续时间。
Am J Med. 2017 Nov;130(11):1325.e1-1325.e12. doi: 10.1016/j.amjmed.2017.05.029. Epub 2017 Jun 13.
6
Epidemiology of coronary heart disease and acute coronary syndrome.冠心病和急性冠脉综合征的流行病学。
Ann Transl Med. 2016 Jul;4(13):256. doi: 10.21037/atm.2016.06.33.
7
Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent: Randomized Substudy of the I-LOVE-IT 2 Trial.生物可降解聚合物西罗莫司洗脱支架植入术后6个月与12个月双重抗血小板治疗的比较:I-LOVE-IT 2试验的随机子研究
Circ Cardiovasc Interv. 2016 Feb;9(2):e003145. doi: 10.1161/CIRCINTERVENTIONS.115.003145.
8
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.急性心肌梗死患者和非急性心肌梗死患者PCI术后延长疗程双重抗血小板治疗的获益与风险
J Am Coll Cardiol. 2015 May 26;65(20):2211-21. doi: 10.1016/j.jacc.2015.03.003. Epub 2015 Mar 15.
9
Heart disease and stroke statistics--2015 update: a report from the American Heart Association.《2015年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2015 Jan 27;131(4):e29-322. doi: 10.1161/CIR.0000000000000152. Epub 2014 Dec 17.
10
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会非ST段抬高型急性冠状动脉综合征患者管理指南:美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Dec 23;130(25):e344-426. doi: 10.1161/CIR.0000000000000134. Epub 2014 Sep 23.

急性冠状动脉综合征患者预防性双联抗血小板治疗的依从性——在沙特一所大学医院开展的一项研究。

Adherence to prophylactic dual antiplatelet therapy in patients with acute coronary syndrome - A study conducted at a Saudi university hospital.

作者信息

Alrabiah Ziyad, Wajid Syed, Alsulaihim Ibrahim, Alghadeer Sultan, Alhossan Abdulaziz, Babelghaith Salmeen D, Al-Arifi Mohamed

机构信息

Clinical Pharmacy Department, College of Pharmacy King Saud University, Saudi Arabia.

出版信息

Saudi Pharm J. 2020 Mar;28(3):369-373. doi: 10.1016/j.jsps.2020.01.018. Epub 2020 Feb 3.

DOI:10.1016/j.jsps.2020.01.018
PMID:32194339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7078558/
Abstract

OBJECTIVES

The aim of this study was to evaluate patients' self-reported adherence to dual antiplatelet therapy (DAPT) and determine the factors associated with premature discontinuation of DAPT.

METHODS

The cross-sectional interview-based study was conducted among adult outpatients who visited the outpatient department of King Khalid University Hospital, Cardiac Center in Riyadh, Saudi Arabia, over a period of 3 months from May to July of 2016. Medication adherence was assessed using the Self-efficacy for Appropriate Medication Use Scale (SEAMS), which is composed of 13 items with a 3-point Likert scale.

RESULTS

A total of 192 patients participated in the study. The majority of the participants were male (82.1%), and the mean age was 55.66 ± 10.80 years. More than 84% (84.4%) of the patients reported that they were "confident" in taking several medications each day. The minimum and maximum SEAMS scores were 22 and 39, respectively, with the mean score being 30.8 ± 3.5. Almost all patients had moderate scores and adherence; only one patient got a score of 39. Among sociodemographic characteristics, only health insurance and income were significantly associated with the medication adherence score (p < 0.05).

CONCLUSIONS

Study results concluded that patients had a moderate level of adherence towards DAPT in Saudi Arabia, however Patient education on DAPT is essential to improve adherence to medication treatment. More effective intentions and education methods should be developed to improve long-term DAPT adherence.

摘要

目的

本研究旨在评估患者自我报告的双联抗血小板治疗(DAPT)依从性,并确定与DAPT提前停药相关的因素。

方法

这项基于访谈的横断面研究于2016年5月至7月的3个月期间,在沙特阿拉伯利雅得哈立德国王大学医院心脏中心门诊就诊的成年门诊患者中进行。使用适当用药自我效能量表(SEAMS)评估药物依从性,该量表由13个项目组成,采用3分李克特量表。

结果

共有192名患者参与了该研究。大多数参与者为男性(82.1%),平均年龄为55.66±10.80岁。超过84%(84.4%)的患者报告称他们对每天服用多种药物“有信心”。SEAMS得分最低为22分,最高为39分,平均得分为30.8±3.5。几乎所有患者的得分和依从性都处于中等水平;只有一名患者得分为39分。在社会人口统计学特征中,只有医疗保险和收入与药物依从性得分显著相关(p<0.05)。

结论

研究结果表明,沙特阿拉伯患者对DAPT的依从性处于中等水平,然而对患者进行DAPT教育对于提高药物治疗依从性至关重要。应制定更有效的策略和教育方法以提高长期DAPT依从性。